Device Trial Radar · NCT05650866
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction
Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
May 19, 2023
Primary completion
Jun 30, 2028
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- Comphya AustraliaNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 14, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Male only, from 30 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up: * Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness. Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.
Conditions
- Erectile Dysfunction Following Radical Prostatectomy
Interventions
Activation of pro-erectile nerves within the pelvic plexusDevice
The study device is an active implantable device. The device activates the cavernous nerves by delivering electrical pulses, to trigger an on-demand erection. The daily delivery of electrical pulses to the cavernous nerves will also allow participants to recover natural erectile function.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of adverse eventsTime frame: 6 months
- Occurrence of surgical complicationsTime frame: 6 months
- Occurrence of device deficienciesTime frame: 6 months
1 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
St. Vincent's Private Hospital
Fitzroy, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
Australian Prostate Centre
North Melbourne, Victoria, Australia
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.